Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
-
Victoria’s Secret & Co. Reports Fourth Quarter 2024 Results
-
CoreCivic Announces Resumption of Operations at South Texas Family Residential Center in Dilley, Texas
-
EVast Bio Achieves World's First Exosome Therapy Application for Knee Osteoarthritis
-
Alta Equipment Group Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Adjusted EBITDA Guidance for 2025
-
COMPX REPORTS FOURTH QUARTER 2024 RESULTS
-
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
-
EVast Bio Achieves World's First Exosome Therapy Application for Knee Osteoarthritis
-
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
-
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
-
Shop LC Hosts Historic 24-Hour Paraiba Tourmaline Event – Rarer Than Diamonds!
-
Rigetti Computing Reports Fourth Quarter and Full-Year 2024 Results
-
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2024 Results
-
Methode Electronics, Inc. Reports Fiscal 2025 Third Quarter Financial Results
-
Global Crossing Airlines Reports Record Fourth Quarter Revenue & Meaningfully Improved Full Year 2024 Financial Results
-
FRP Holdings, Inc. (NASDAQ: FRPH) Announces Results for the Fourth Quarter and Year Ended December 31, 2024
-
Zscaler Reports Second Quarter Fiscal 2025 Financial Results
-
Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
-
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
-
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
-
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Hub Group Declares Quarterly Dividend
-
Amplify Energy Announces Fourth Quarter and Full-Year 2024 Results, Year-End 2024 Proved Reserves, Juniper Capital Acquisition Update and Standalone Full-Year 2025 Guidance
-
Lesaka completes the acquisition of Recharger
-
Micron Appoints Mark Liu and Christie Simons to Board of Directors
-
Enovis to Participate in Upcoming Investor Conferences
-
ACM Research to Participate at the 37th Annual ROTH Conference
-
Silvaco Reports Fourth Quarter and Full Year 2024 Financial Results
-
Climb Global Solutions Reports Record Fourth Quarter and Full Year 2024 Results
-
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
-
Lesaka completes the acquisition of Recharger
-
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
-
Aware Reports Fourth Quarter and Full Year 2024 Financial Results
-
CPS Technologies Announces Phase I SBIR Contract from the U.S. Army
-
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Plus Therapeutics Announces New Employment Inducement Grants
-
CompoSecure Reports Fourth Quarter and Full Year 2024 Financial Results
-
Five Below, Inc. Announces Fourth Quarter and Full Year Fiscal 2024 Earnings Release and Conference Call Date
-
Linamar Delivers Record Sales over $10 Billion, Exceptional Free Cash Flow and Another Year of Double-Digit Earnings Growth
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
DNB Financial Group Introduces Risk Management Tools for UK Investors
-
OTC Markets Group Announces Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast
-
GraniteShares ETFs Announces Name Change and Investment Objectives on some of its Short and Leveraged ETFs
-
Parting Stone Celebrates Serving 10,000 Families with Solidified Remains Service
